Status:
COMPLETED
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This single arm study will evaluate the efficacy and safety of sequential treatment with Diavobet (betamethasone propionate 0.5mg/g plus calcipotriol hydrate 50 micrograms/g) once daily for 4 weeks fo...
Eligibility Criteria
Inclusion
- adult patients \>=18 years of age;
- clinical diagnosis of psoriasis vulgaris;
- PASI score 1-12 in \>=1 body area.
Exclusion
- clinical presentation of erythrodermic pustular psoriasis, expressed in plates and localized lesions on face and/or scalp;
- viral, fungal or bacterial skin infections;
- use of any topical treatment for psoriasis within previous 15 days;
- use of any systemic therapy and phototherapy for psoriasis within previous 30 days.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00437619
Start Date
February 1 2007
End Date
August 1 2009
Last Update
December 2 2015
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Belém, Brazil, 66087-670
2
Belo Horizonte, Brazil, 30150-221
3
Botucatu, Brazil, 18618-000
4
Brasília, Brazil, 70840-901